Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Non-Malignant Oligoclonal Hematopoiesis Commonly Follows Cytoreductive Chemotherapy in Adult De Novo AML Patients

Terrence Neal Wong, MDPhD, Jeffery M. Klco, MDPhD, Ryan Demeter, Christopher A. Miller, PhD, Allegra Petti, PhD, Nichole Havey, Robert Fulton, PhD, Sharon Heath, Elaine R Mardis, PhD, Peter Westervelt, MD PhD, John F. DiPersio, MD PhD, Matthew J. Walter, MD, John S. Welch, MD PhD, Timothy Graubert, MD, Richard K Wilson, PhD, Timothy J. Ley, MD, Daniel C. Link, MD

Blood (2015) 126 (23): 686.

https://doi.org/10.1182/blood.V126.23.686.686

Published: 2015

Journal Articles

Allele-Specific Effects Of U2AF1 Mutations On Alternative Splicing

Theresa Okeyo-Owuor, Brian S. White, PhD, Dipika Mohan, Malachi Griffith, PhD, Matthew J. Walter, MD, Timothy Graubert, MD

Blood (2013) 122 (21): 2748.

https://doi.org/10.1182/blood.V122.21.2748.2748

Published: 2013

Journal Articles

A Phase I Study Of Azacitidine After Donor Lymphocyte Infusion For Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Armin Ghobadi, MD, Mark A. Fiala, BS, CCRP, Camille N. Abboud, MD, Amanda F Cashen, MD, Linda Eissenberg, PhD, Timothy Graubert, MD, Meagan A Jacoby, MD/PhD, Iskra Pusic, MD, Mark A. Schroeder, MD, Keith E. Stockerl-Goldstein, MD, Michael H. Tomasson, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Matthew J. Walter, MD, John F. DiPersio, MD, PhD, Peter Westervelt, MD, PhD

Blood (2013) 122 (21): 3320.

https://doi.org/10.1182/blood.V122.21.3320.3320

Published: 2013

Journal Articles

The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML

Terrence Neal Wong, MD PhD, Giridharan Ramsingh, M.D, Andrew Young, Dong Shen, Chris Miller, PhD, Tamara Lamprecht, B.S., Sharon Heath, Robert S. Fulton, Elaine R. Mardis, PhD, Li Ding, Peter Westervelt, MD, PhD, John Welch, PhD/MD, Matthew J. Walter, MD, Timothy Graubert, MD, John F. DiPersio, MD, PhD, Timothy J. Ley, MD, Todd E Druley, MD, PhD, Richard K Wilson, PhD, Daniel C. Link, MD

Blood (2013) 122 (21): 5.

https://doi.org/10.1182/blood.V122.21.5.5

Published: 2013

Journal Articles

Mutant U2AF1(S34F) Expression Alters Hematopoiesis in Mice

Cara L Lunn, Ph.D., Justin Tibbitts, MS MBA, James N Ley, Jin Shao, Timothy Graubert, MD, Matthew J. Walter, MD

Blood (2012) 120 (21): 553.

https://doi.org/10.1182/blood.V120.21.553.553

Published: 2012

Journal Articles

Complete Sequencing and Comparison of 12 Normal Karyotype M1 AML Genomes with 12 t(15;17) Positive M3-APL Genomes

Blood (2011) 118 (21): 404.

https://doi.org/10.1182/blood.V118.21.404.404

Published: 2011

Journal Articles

BRCA1 and BRCA2 Nucleotide Variants in Young Women with Therapy Related Acute Myeloid Leukemia.

Michael G. Martin, MD, Meagan Jacoby, MD, Jin Shao, Elena Deych, PhD, Timothy Graubert, MD, Matthew J. Walter, MD

Blood (2009) 114 (22): 1102.

https://doi.org/10.1182/blood.V114.22.1102.1102

Published: 2009

Journal Articles

Caspase-9: A Candidate Susceptibility Factor for Murine Alkylator-Induced Leukemia.

Yedda Li, Patrick Cahan, Masayo Izumi, Timothy Graubert, MD

Blood (2009) 114 (22): 1273.

https://doi.org/10.1182/blood.V114.22.1273.1273

Published: 2009

Journal Articles

A Genome-Wide Analysis to Identify Novel Susceptibility Loci for Therapy-Related Acute Myeloid Leukemia

Kenan Onel, MD, PhD, Jeffrey A Knight, Andrew D Skol, PhD, Thelma R Tennant, Mekhala Banerjee, Richard Walgren, MD, PhD, Jin Shao, James M Allan, MD, Michelle M Le Beau, PhD, Richard A Larson, MD, Timothy Graubert, MD, Nancy J Cox, PhD

Blood (2008) 112 (11): 432.

https://doi.org/10.1182/blood.V112.11.432.432

Published: 2008

Journal Articles

Bcl2, a Candidate Murine Therapy-Related Acute Myeloid Leukemia Susceptibility Factor, Exhibits Strain-Dependent and Alkylator-Responsive Expression.

Ryan Funk, BS, Patrick Cahan, Masayo Izumi, Timothy Graubert, MD

Blood (2008) 112 (11): 1499.

https://doi.org/10.1182/blood.V112.11.1499.1499

Published: 2008

Journal Articles

Genetic Susceptibility to Therapy-Related Acute Murine Promyelocytic Leukemia.

Ryan K. Funk, BS, Taylor Maxwell, PhD, Masayo Izumi, BA, Deepa Edwin, PhD, Friederike Kreisel, MD, James Cheverud, PhD, Timothy J. Ley, MD, Timothy Graubert, MD

Blood (2007) 110 (11): 14.

https://doi.org/10.1182/blood.V110.11.14.14

Published: 2007

Journal Articles

A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.

Richard Walgren, MD, PhD, Crystal Dao, MA, Frederieke Kreisel, MD, Peter Westervelt, MD, PhD, Camille Abboud, MD, Timothy Graubert, MD, Amanda Cashen, MD, Geoffrey Uy, MD, Feng Gao, MD, John DiPersio, MD, PhD, Ravi Vij, MD

Blood (2007) 110 (11): 1451.

https://doi.org/10.1182/blood.V110.11.1451.1451

Published: 2007

Journal Articles

Identification of Polymorphisms Associated with Susceptibility to Therapy-Related MDS and AML.

Richard Walgren, MD, PhD, Edward McLaughlin, BSc, Elise Peterson, BS, Michael Crosswhite, MA, Michael Province, PhD, Howard McLeod, PharmD, Timothy Ley, MD, Timothy Graubert, MD, Gareth Morgan, MD, PhD

Blood (2007) 110 (11): 15.

https://doi.org/10.1182/blood.V110.11.15.15

Published: 2007

Journal Articles

A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.

Tom Fong, MD, Kim Trinkaus, PhD, Douglas R. Adkins, MD, Ravi Vij, MD, Steven Devine, MD, Michael Tomasson, MD, Lawrence T. Goodnough, MD, Timothy Graubert, MD, Shalini Shenoy, MD, John F. DiPersio, MD, PhD, Hanna J. Khoury, MD

Blood (2005) 106 (11): 1800.

https://doi.org/10.1182/blood.V106.11.1800.1800

Published: 2005

NARROW

Non-Malignant Oligoclonal Hematopoiesis Commonly Follows Cytoreductive Chemotherapy in Adult De Novo AML Patients

Allele-Specific Effects Of U2AF1 Mutations On Alternative Splicing

A Phase I Study Of Azacitidine After Donor Lymphocyte Infusion For Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML

Mutant U2AF1(S34F) Expression Alters Hematopoiesis in Mice

Complete Sequencing and Comparison of 12 Normal Karyotype M1 AML Genomes with 12 t(15;17) Positive M3-APL Genomes

BRCA1 and BRCA2 Nucleotide Variants in Young Women with Therapy Related Acute Myeloid Leukemia.

Caspase-9: A Candidate Susceptibility Factor for Murine Alkylator-Induced Leukemia.

A Genome-Wide Analysis to Identify Novel Susceptibility Loci for Therapy-Related Acute Myeloid Leukemia

Bcl2, a Candidate Murine Therapy-Related Acute Myeloid Leukemia Susceptibility Factor, Exhibits Strain-Dependent and Alkylator-Responsive Expression.

Genetic Susceptibility to Therapy-Related Acute Murine Promyelocytic Leukemia.

A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.

Identification of Polymorphisms Associated with Susceptibility to Therapy-Related MDS and AML.

A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only